Latest News
|
15 April 2013
0 Likes 
Depending upon whom you ask, a case to be heard by the US Supreme Court on Monday will either mark a massive blow to the biotechnology industry and its regulated products or a massive blow to the
Read More...
Latest News
|
5 March 2013
0 Likes
An Amicus Curiae brief filed by the Generic Pharmaceutical Association (GPhA) with the Supreme Court of the US seeks to uphold patent settlements—otherwise known as "pay-for-delay" settlements—arguing
Read More...
Latest News
|
5 October 2012
0 Likes
The US Federal Trade Commission (FTC) is calling on the US Supreme Court to review a so-called "pay-for-delay" case concerning generic and branded versions of AndroGel, a topical testosterone
Read More...
Latest News
|
19 April 2012
0 Likes
After the Supreme Court of the US ruled in its controversial Pliva v. Mensing decision that generic pharmaceutical manufacturers are not liable for tort claims based on labeling because federal law
Read More...
Latest News
|
28 March 2012
0 Likes
The Supreme Court of the United States (SCOTUS) is scheduled to hear arguments today on the Patient Protection and Affordable Care Act’s (PPACA) Medicaid expansion provisions and whether the
Read More...
Latest News
|
27 March 2012
0 Likes
The Supreme Court of the United States (SCOTUS) ruled Monday (26 March) to send a case by Myriad Genetics Inc. back to a lower court for review in light of its recent decision, Mayo Collaborative
Read More...
Latest News
|
27 March 2012
0 Likes
The Supreme Court of the United States (SCOTUS) is scheduled to hear arguments today on the Patient Protection and Affordable Care Act’s (PPACA) ‘individual mandate’ provisions. In preparation for
Read More...
Latest News
|
26 March 2012
0 Likes
The Supreme Court of the United States (SCOTUS) is scheduled to hear three days of arguments on the Patient Protection and Affordable Care Act (PPACA) starting Monday, 26 March. In preparation for
Read More...
Latest News
|
20 March 2012
0 Likes
The Supreme Court of the US (SCOTUS) ruled 20 March that Prometheus Laboratories, a subsidiary of Nestle, could not patent a method to determine the proper dosing for a disease, reports Reuters.The
Read More...
Latest News
|
12 March 2012
0 Likes
The Supreme Court of the United States (SCOTUS) will hear a series of challenges to the 2010 Patient Protection and Affordable Care Act (PPACA) of 2010 on 26-28 March, marking a historic challenge to
Read More...